Edgestream Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,544
| Closed | -$467K | – | 597 |
|
|
2021
Q2 | $467K | Buy |
+2,544
| New | +$467K | 0.03% | 361 |
|
|
2021
Q1 | – | Sell |
-9,419
| Closed | -$1.47M | – | 462 |
|
|
2020
Q4 | $1.47M | Buy |
+9,419
| New | +$1.47M | 0.07% | 263 |
|
|
2018
Q3 | – | Sell |
-20,130
| Closed | -$2.5M | – | 354 |
|
|
2018
Q2 | $2.5M | Buy |
+20,130
| New | +$2.5M | 0.51% | 66 |
|